Additionally, CAF-derived VEGFA upregulates METTL3 in NSCLC cells and activates the AKT/NF-κB pathway via RAC3, further promoting m6A methylation and enhancing tumor migration and invasion (143). Here, VEGFA is linked to non-small cell lung carcinoma.